Wisconsin Collaborative for Quality Healthcare

View Our Reports

print this pagefeedback survey

The results below represent 643,773 men and women who should have had a colorectal cancer screening. Read More About This Measure

Reporting Period:

Sort By Rank | Sort By Name  
Btn Export
Gundersen Clinic, Ltd
80.86 %
View Historical Data
UW Health Physicians
78.88 %
View Historical Data
Prevea Health
77.61 %
View Historical Data
NOTE: Corrected results displaying effective 7/26/12
ThedaCare Physicians
77.48 %
View Historical Data
Dean Clinic
75.43 %
View Historical Data
Bellin Medical Group
74.45 %
View Historical Data
Marshfield Clinic
73.56 %
View Historical Data
Aurora Health Care Medical Group
73.01 %
View Historical Data
ProHealth Care Medical Associates
70.62 %
View Historical Data
Mayo Clinic Health System in Eau Claire
N=25479 n=14431
70.03 %
View Historical Data
Wheaton Franciscan Medical Group
N=44921 n=24318
69.66 %
View Historical Data
Aurora UW Medical Group
69.21 %
View Historical Data
Columbia St. Mary's Community Physicians
N=37002 n=20959
66.48 %
View Historical Data
Mayo Clinic Health System - Franciscan Healthcare
65.88 %
View Historical Data
Monroe Clinic
65.37 %
View Historical Data
Mercy Health System
N=26543 n=13915
62.54 %
View Historical Data
Aurora Advanced Healthcare

Did Not Report
View Historical Data

The United States Preventive Services Task Force (USPSTF) strongly recommends that clinicians screen men and women, at age 50 and older for colorectal cancer. The optimal interval for screening depends on the test. Annual fecal occult blood testing (FOBT)/Fecal Immunoassay Test (FIT) offers greater reductions in mortality rates than biennial screening. A 10-year interval has been recommended for colonoscopy, but a 5-year interval is recommended for flexible sigmoidoscopies because of their lower sensitivity. Fecal DNA Screening (Cologuard test) has been added as a new option for screening in 2015 (recommended interval every three years). The USPSTF concluded that the benefits from screening for colorectal cancer substantially outweigh potential harms, and that regardless of screening strategy chosen, it is likely to be cost-effective. In persons identified as being at high-risk by their health care providers, initiating screening at an earlier age is reasonable. It is recommended that all adults speak with their health care providers to determine, on an individual basis, the age at which to begin and end screenings, the best type of screening for individual circumstances, and the frequency of these screenings.

Disclaimer: Measures reported by WCHQ healthcare organizations represent a specific aspect of care in relation to an evidence-based standard, but are not clinical guidelines and do not establish standards of care.